UK Firms Asked To Check Coronavirus Supply Chain Impact
Authorities Also Investing In Vaccines And Tests
Executive Summary
Amid concerns that the coronavirus outbreak could have an impact on the supply of APIs and other materials sourced from Chinese manufacturers, pharmaceutical companies are to assess their supply chain situation to help ensure patients do not experience medicine shortages.
You may also be interested in...
Get Stockpiling Now, Industry Urges UK Government
An internal memo has revealed the extent of the pharmaceutical industry’s worries over serious product shortages amid the COVID-19 pandemic and the possibility that the UK and the EU will fail to agree a trade deal by the end of 2020.
Coronavirus Supply Chain Threats Demand Coordinated Industry Response
Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.
EU Firms Called In As Coronavirus Cases Soar
With cases of novel coronavirus infection rising at an alarming rate, the industry in Europe is being urged to contribute what it can by way of new products for detecting, diagnosing or treating the disease. Several research projects are also being run or started up with EU funding.